BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
SLC12A1
,
nitric oxide metabolic process
,
Obesity
,
Adipose tissue
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
risk cardiovascular event
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Carotid plaque gene expression associated with ischemic events in endarterectomy patients
Whole blood samples from acute coronary syndrome (ACS) patients aspirin sensitive or resistant
Peripheral blood samples of myocardial infarction patients recurrent or non-recurrent
Blood of systemic lupus erythematosus patients with rs7574865 risk allele treated with tofacitinib
Cardiac muscle gene expression profiles over a timecourse following 14d rosiglitazone treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
Placental Abruption and Cardiovascular Event Risk (PACER): Design, data linkage, and preliminary fin…
POST EVENT-CARDIOVASCULAR RISK PERCEPTION SURVEY: VALIDITY AND RELIABILITY IN CARDIAC PATIENTS POST …
Proteomic Assessment of the Risk of Secondary Cardiovascular Events among Individuals with CKD.
Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes…
A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascu…
Systolic Pressure Index in Assessing the Risk of Cardiovascular Events
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascul…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ